DNMT3A and acute myeloid leukemia: To further explore the underlying mechanism of the clinical and prognostic differences between AML patients carrying DNMT3A R882 and DNMT3A frameshift mutations, we retrieved the mRNA sequencing and miRNA profiling data from 12 AML patients from the TCGA database, as described above.